SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-073046
Filing Date
2024-06-13
Accepted
2024-06-13 16:22:58
Documents
14
Period of Report
2024-06-13
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nktx-20240613.htm   iXBRL 8-K 70271
2 EX-3.1 nktx-ex3_1.htm EX-3.1 11458
3 EX-99.1 nktx-ex99_1.htm EX-99.1 21764
4 GRAPHIC img220989892_0.jpg GRAPHIC 17658
  Complete submission text file 0000950170-24-073046.txt   257828

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nktx-20240613.xsd EX-101.SCH 28184
17 EXTRACTED XBRL INSTANCE DOCUMENT nktx-20240613_htm.xml XML 4886
Mailing Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 (925) 407-1049
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39370 | Film No.: 241041547
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)